Connection

Amarendra Neppalli to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Amarendra Neppalli has written about Antibodies, Monoclonal, Humanized.
Amarendra Neppalli
Connection Strength
0.037
Antibodies, Monoclonal, Humanized
  1. Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy. Leukemia. 2019 09; 33(9):2266-2275.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.